Results 191 to 200 of about 125,716 (297)
Effects of rifaximin in fructose-induced steatohepatitis in rats. [PDF]
Celik NC +6 more
europepmc +1 more source
Changes in LXRα phosphorylation promote a novel diet-induced transcriptome that alters the transition from fatty liver to steatohepatitis [PDF]
Natalia Bécares +17 more
openalex +1 more source
ABSTRACT Objective This post hoc analysis assessed psychiatric changes with tirzepatide in adults with obesity, without known major psychopathology, from SURMOUNT‐1, SURMOUNT‐2, and SURMOUNT‐3. Methods In participants (N = 4056) treated with tirzepatide (5/10/15 mg or maximum tolerated dose 10/15 mg) versus placebo, depressive symptoms and suicidal ...
Thomas A. Wadden +6 more
wiley +1 more source
Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind: author's reply. [PDF]
Lazarus JV +4 more
europepmc +1 more source
Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis: A Narrative Review. [PDF]
Zacharia GS +3 more
europepmc +1 more source
Bardoxolone methyl prevents metabolic dysfunction‐associated steatohepatitis by inhibiting macrophage infiltration [PDF]
Kazuhiro Onuma +5 more
openalex +1 more source
Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley +1 more source
Correction: Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice. [PDF]
Nan Y +8 more
europepmc +1 more source

